These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 2064338)

  • 1. Plasma acid and alkaline phosphatase in patients with breast cancer.
    Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A
    Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
    Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
    Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of two serum isoenzyme phosphatases as bone metastasis markers].
    Desoize B; Pourny C; Amico S; Larbre H; Jardillier JC
    Bull Cancer; 1990; 77(12):1211-21. PubMed ID: 2081281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase.
    Wolff JM; Ittel TH; Borchers H; Boekels O; Jakse G
    Anticancer Res; 1999; 19(4A):2653-5. PubMed ID: 10470213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
    Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
    Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ostase in the follow-up of breast cancer patients.
    Marchei P; Santini D; Bianco V; Chiodini S; Reale MG; Simeoni F; Marchei GG; Vecchione A
    Anticancer Res; 1995; 15(5B):2217-22. PubMed ID: 8572628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte alkaline phosphatase and serum alkaline phosphatase in patients with metastatic breast and colon cancer.
    Walach N; Gur Y
    Neoplasma; 1996; 43(5):297-300. PubMed ID: 8996547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
    Koizumi M; Takahashi S; Ogata E
    Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bone alkaline phosphatase in the follow-up of skeletal metastases.
    Zaninotto M; Secchiero S; Rubin D; Sciacovelli L; Trovò M; Bortolus R; Plebani M
    Anticancer Res; 1995; 15(5B):2223-8. PubMed ID: 8572629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkaline phosphatase isoenzymes for the diagnosis of metastatic tumors and lymphomas of liver and bone.
    Yorio MA; Sembaj A; Sanz E; Carriazo C; Moreno Barral J
    Medicina (B Aires); 2000; 60(3):311-5. PubMed ID: 11050806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
    Ritzke C; Stieber P; Untch M; Nagel D; Eiermann W; Fateh-Moghadam A
    Anticancer Res; 1998; 18(2B):1243-9. PubMed ID: 9615795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.
    Kanakis I; Nikolaou M; Pectasides D; Kiamouris C; Karamanos NK
    J Pharm Biomed Anal; 2004 Mar; 34(4):827-32. PubMed ID: 15019061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma.
    Desoize B; Amico S; Larbre H; Coninx P; Jardillier JC
    Clin Biochem; 1991 Oct; 24(5):443-6. PubMed ID: 1760884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [General activity and isoenzymatic spectrum of alkaline phosphatase in the diagnosis of breast cancer metastases].
    Pashintseva LP; Portnoĭ SM
    Vestn Khir Im I I Grek; 1981 Jan; 126(1):62-6. PubMed ID: 7222422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tartrate-resistant acid phosphatase in the detection of bone metastasis in patients with cancer].
    Filmus J; Podhajcer OL; Mordoh J; Roca E; Cedaro L; Chacón RD
    Medicina (B Aires); 1982; 42(6 Pt 1):655-8. PubMed ID: 7183891
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer.
    Korpela J; Tiitinen SL; Hiekkanen H; Halleen JM; Selander KS; Väänänen HK; Suominen P; Helenius H; Salminen E
    Anticancer Res; 2006; 26(4B):3127-32. PubMed ID: 16886645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal serum alkaline and acid phosphatase isoenzymes in female breast cancer patients.
    Agbedana EO; Ebesunun MO
    Afr J Med Med Sci; 1998; 27(1-2):65-9. PubMed ID: 10456133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
    Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
    Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M
    Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The biochemical markers of bone remodeling in cancer patients with skeletal involvement].
    Liubimova NV; Bronnikov IIu; Robins SP; Trapeznikova MF; Kushlinskiĭ NE
    Vopr Onkol; 2000; 46(3):290-7. PubMed ID: 10976274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.